Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Breast cancer
Closed
Phase 2
This trial is looking at palbociclib and hormone therapy for women who are newly diagnosed with breast cancer.
And whose cancer has receptors for the hormone oestrogen () but doesn’t have receptors for (HER2 negative).
Cancer Research UK supports this trial.
Recruitment start: 9 September 2020
Recruitment end: 31 July 2022
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Carlo Palmieri
Cancer Research UK
Pfizer
University of Liverpool
Last reviewed: 6 January 2023
CRUK internal database number: 16745
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
